Literature DB >> 16041401

Effect of clopidogrel on the expression of inflammatory markers in rabbit ischemic coronary artery.

Laura Molero1, Antonio López-Farré, Petra J Mateos-Cáceres, Ruth Fernández-Sánchez, María Luisa Maestro, Jacobo Silva, Enrique Rodríguez, Carlos Macaya.   

Abstract

Inflammation and platelet activation are critical phenomena in the setting of acute coronary syndromes. Platelets may contribute to increase ischemic injury by enhancing the inflammatory response of leukocytes and endothelial myocardial cells. Pharmacological inhibition of platelet activation prevents ischemic complications in patients with coronary diseases. Agents directed against the integrin glycoprotein IIb/IIIa (GP IIb/IIIa) receptor not only inhibit platelet aggregation but also have been demonstrated to limit the inflammatory response in acute coronary syndromes. The question then raised is if the inhibition of platelet activation by other mechanisms than the blockade of GP IIb/IIIa may also exert anti-inflammatory effects. The aim of the present study was to analyze if clopidogrel may exert anti-inflammatory effects during the acute phase of myocardial infarction. A ligature was placed around the left anterior descending coronary artery of New Zealand White rabbits. After 15 min of ischemia, the myocardium was reperfused and the ischemic coronary artery was isolated 24 h after the ischemia. A group of ischemic rabbits was given a single oral dose of clopidogrel (20 mg kg(-1)) just after the arterial occlusion and the animal was recovered. Sham-operated animals served as control. P-selectin expression was significantly increased in infarcted rabbits with respect to control rabbits. Clopidogrel administration reduced P-selectin expression with respect to untreated infarcted rabbits. CD40 ligand and tissue factor expression was increased in the ischemic coronary artery and reduced after clopidogrel administration. Clopidogrel also protected endothelial nitric oxide synthase protein expression in the ischemic coronary artery, a protein that has been found downregulated under inflammatory conditions. In conclusion, inhibition of platelet activation by clopidogrel exerted anti-inflammatory effects on the ischemic coronary artery.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16041401      PMCID: PMC1576286          DOI: 10.1038/sj.bjp.0706340

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

1.  Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets.

Authors:  F J Neumann; N Marx; M Gawaz; K Brand; I Ott; C Rokitta; C Sticherling; C Meinl; A May; A Schömig
Journal:  Circulation       Date:  1997-05-20       Impact factor: 29.690

Review 2.  Regulation of the tissue factor gene.

Authors:  N Mackman
Journal:  Thromb Haemost       Date:  1997-07       Impact factor: 5.249

3.  Fluoroenzymometric method to measure cardiac troponin I in sera of patients with myocardial infarction.

Authors:  M Zaninotto; S Altinier; M Lachin; P Carraro; M Plebani
Journal:  Clin Chem       Date:  1996-09       Impact factor: 8.327

4.  Differential reactivity of cardiac and skeletal muscle from various species in a cardiac troponin I immunoassay.

Authors:  P J O'Brien; Y Landt; J H Ladenson
Journal:  Clin Chem       Date:  1997-12       Impact factor: 8.327

5.  Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability.

Authors:  L M Biasucci; G Liuzzo; R L Grillo; G Caligiuri; A G Rebuzzi; A Buffon; F Summaria; F Ginnetti; G Fadda; A Maseri
Journal:  Circulation       Date:  1999-02-23       Impact factor: 29.690

6.  Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life.

Authors:  M Yoshizumi; M A Perrella; J C Burnett; M E Lee
Journal:  Circ Res       Date:  1993-07       Impact factor: 17.367

7.  C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction.

Authors:  D A Morrow; N Rifai; E M Antman; D L Weiner; C H McCabe; C P Cannon; E Braunwald
Journal:  J Am Coll Cardiol       Date:  1998-06       Impact factor: 24.094

8.  Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells.

Authors:  M Gawaz; F J Neumann; T Dickfeld; W Koch; K L Laugwitz; H Adelsberger; K Langenbrink; S Page; D Neumeier; A Schömig; K Brand
Journal:  Circulation       Date:  1998-09-22       Impact factor: 29.690

9.  The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit.

Authors:  J M Herbert; F Dol; A Bernat; R Falotico; A Lalé; P Savi
Journal:  Thromb Haemost       Date:  1998-09       Impact factor: 5.249

10.  The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina.

Authors:  G Liuzzo; L M Biasucci; J R Gallimore; R L Grillo; A G Rebuzzi; M B Pepys; A Maseri
Journal:  N Engl J Med       Date:  1994-08-18       Impact factor: 91.245

View more
  9 in total

1.  Platelets are relevant mediators of renal injury induced by primary endothelial lesions.

Authors:  Claudia Schwarzenberger; Jan Sradnick; Kenneth M Lerea; Michael S Goligorsky; Bernhard Nieswandt; Christian P M Hugo; Bernd Hohenstein
Journal:  Am J Physiol Renal Physiol       Date:  2015-04-01

Review 2.  Beyond platelet inhibition: potential pleiotropic effects of ADP-receptor antagonists.

Authors:  Srinivas Iyengar; LeRoy E Rabbani
Journal:  J Thromb Thrombolysis       Date:  2008-04-09       Impact factor: 2.300

Review 3.  Translational initiatives in thrombolytic therapy.

Authors:  Melvin E Klegerman
Journal:  Front Med       Date:  2017-03-02       Impact factor: 4.592

Review 4.  Effects of P2Y12 receptor antagonists beyond platelet inhibition--comparison of ticagrelor with thienopyridines.

Authors:  Sven Nylander; Rainer Schulz
Journal:  Br J Pharmacol       Date:  2016-02-24       Impact factor: 8.739

5.  Pretreatment with a combination of ligustrazine and berberine improves cardiac function in rats with coronary microembolization.

Authors:  Ying Zhang; Xiao-juan Ma; Chun-yu Guo; Ming-ming Wang; Na Kou; Hua Qu; Hui-min Mao; Da-zhuo Shi
Journal:  Acta Pharmacol Sin       Date:  2016-02-29       Impact factor: 6.150

6.  Clopidogrel preserves whole kidney autoregulatory behavior in ANG II-induced hypertension.

Authors:  David A Osmond; Shali Zhang; Jennifer S Pollock; Tatsuo Yamamoto; Carmen De Miguel; Edward W Inscho
Journal:  Am J Physiol Renal Physiol       Date:  2014-01-29

7.  Anti-inflammatory renoprotective effect of clopidogrel and irbesartan in chronic renal injury.

Authors:  Xiaowen Tu; Xiangmei Chen; Yuansheng Xie; Suozhu Shi; Jianzhong Wang; Yunshuang Chen; Jianjun Li
Journal:  J Am Soc Nephrol       Date:  2007-11-28       Impact factor: 10.121

8.  The roles of buyang huanwu decoction in anti-inflammation, antioxidation and regulation of lipid metabolism in rats with myocardial ischemia.

Authors:  Yu Liu; Rong Lin; Xiaolian Shi; Zhiyuan Fang; Weirong Wang; Qinqin Lin; Jiye Zhang; Hui Zhang; Qiaoli Ji
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-10       Impact factor: 2.629

9.  Differential immunological profiles herald magnetic resonance imaging-defined perioperative cerebral infarction.

Authors:  Jonathon P Fanning; Louise E See Hoe; Margaret R Passmore; Adrian G Barnett; Barbara E Rolfe; Jonathan E Millar; Allan J Wesley; Jacky Suen; John F Fraser
Journal:  Ther Adv Neurol Disord       Date:  2018-03-13       Impact factor: 6.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.